The global anticoagulants market is projected to grow at a steady rate during the forecast period attributable to launch of drugs with lower side effects and higher efficacy, growing prevalence of cardiovascular diseases globally and higher adoption of novel oral anticoagulants (NOACs) in North America and Europe.